The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices voted 10-4 with one abstention to recommend the Janssen Johnson & Johnson vaccine for persons age 18 and over, under the Food and Drug Administration’s Emergency Use Authorization.
CDC committee reaffirms Johnson & Johnson vaccine recommendation
